These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35983809)

  • 1. Efficacy of Adjusted Dose Tadalafil for Treating Erectile Dysfunction in Patients on Chronic Hemodialysis.
    Ozgur BC; Keseroglu BB
    Arch Esp Urol; 2022 Jun; 75(5):400-404. PubMed ID: 35983809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
    Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
    J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
    Montorsi F; Aversa A; Moncada I; Perimenis P; Porst H; Barker C; Shane MA; Sorsaburu S
    J Sex Med; 2011 Sep; 8(9):2617-24. PubMed ID: 21707928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials.
    Rosen RC; Shabsigh R; Kuritzky L; Wang WC; Sides GD
    Curr Med Res Opin; 2005 Nov; 21(11):1701-9. PubMed ID: 16307689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tadalafil improves erectile dysfunction and quality of life in men with cirrhosis: a randomized double blind placebo controlled trial.
    Jagdish RK; Kamaal A; Shasthry SM; Benjamin J; Maiwall R; Jindal A; Choudhary A; Rajan V; Arora V; Bhardwaj A; Kumar G; Kumar M; Sarin SK
    Hepatol Int; 2023 Apr; 17(2):434-451. PubMed ID: 34775577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
    Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
    Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.
    Glina S; Roehrborn CG; Esen A; Plekhanov A; Sorsaburu S; Henneges C; Büttner H; Viktrup L
    J Sex Med; 2015 Jan; 12(1):129-38. PubMed ID: 25353053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 12 weeks of tadalafil treatment on ejaculatory and orgasmic dysfunction and sexual satisfaction in patients with mild to severe erectile dysfunction: integrated analysis of 17 placebo-controlled studies.
    Paduch DA; Bolyakov A; Polzer PK; Watts SD
    BJU Int; 2013 Feb; 111(2):334-43. PubMed ID: 23356749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
    Shabsigh R; Seftel AD; Kim ED; Ni X; Burns PR
    J Sex Med; 2013 Mar; 10(3):844-56. PubMed ID: 23035781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of erectile dysfunction in men with type 2 diabetes mellitus.
    Hamidi Madani A; Asadolahzade A; Mokhtari G; Shahrokhi Damavand R; Farzan A; Esmaeili S
    J Sex Med; 2013 Apr; 10(4):1146-50. PubMed ID: 23347176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
    Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
    J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tadalafil is efficacious in Black American and Hispanic men with erectile dysfunction: results from multiple observations in men with erectile dysfunction in national tadalafil study in the US (MOMENTUS).
    Gomery P; Bullock A; McGettigan J; Munarriz R; Natanegara F; Hague J; Kuepfer C; Ahuja S; Wong D
    Int J Impot Res; 2007; 19(1):76-83. PubMed ID: 16728966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.
    Egerdie RB; Auerbach S; Roehrborn CG; Costa P; Garza MS; Esler AL; Wong DG; Secrest RJ
    J Sex Med; 2012 Jan; 9(1):271-81. PubMed ID: 21981682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, safety, and treatment satisfaction of tadalafil versus placebo in patients with erectile dysfunction evaluated at tertiary-care academic centers.
    Carson C; Shabsigh R; Segal S; Murphy A; Fredlund P; Kuepfer C;
    Urology; 2005 Feb; 65(2):353-9. PubMed ID: 15708052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of combination treatment with low-intensity shockwave therapy and daily tadalafil on severe erectile dysfunction: a double-blind, randomized, sham-controlled clinical trial.
    Kalyvianakis D; Mykoniatis I; Pyrgidis N; Kapoteli P; Zilotis F; Hatzichristou D
    J Sex Med; 2024 May; 21(6):533-538. PubMed ID: 38600694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
    Porst H; Gacci M; Büttner H; Henneges C; Boess F
    Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial.
    Carrier S; Brock GB; Pommerville PJ; Shin J; Anglin G; Whitaker S; Beasley CM
    J Sex Med; 2005 Sep; 2(5):685-98. PubMed ID: 16422827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.